Histosonics: Robot-assisted sonic therapy to kill cancer
Ann Arbor, Mich. and Minneapolis
Histosonics is developing a robot-assisted platform that uses focused sound energy to target and destroy diseased tissue and tumors at sub-cellular levels. The company announced last month that had closed on a $54 million Series C round led by Varian Medical Systems,
The company’s Robotically Assisted Sonic Therapy (RAST) technology is based on research work done at the University of Michigan.